Sagimet Biosciences (SGMT) Cash & Current Investments: 2023-2024
Historic Cash & Current Investments for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to $152.5 million.
- Sagimet Biosciences' Cash & Current Investments rose 49.73% to $152.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $607.5 million, marking a year-over-year change of. This contributed to the annual value of $94.9 million for FY2023, which is N/A change from last year.
- According to the latest figures from Q3 2024, Sagimet Biosciences' Cash & Current Investments is $152.5 million, which was down 8.35% from $166.4 million recorded in Q2 2024.
- Over the past 5 years, Sagimet Biosciences' Cash & Current Investments peaked at $193.7 million during Q1 2024, and registered a low of $18.5 million during Q2 2023.
- Moreover, its 2-year median value for Cash & Current Investments was $127.2 million (2023), whereas its average is $121.3 million.
- Data for Sagimet Biosciences' Cash & Current Investments shows a peak YoY spiked of 798.92% (in 2024) over the last 5 years.
- Over the past 2 years, Sagimet Biosciences' Cash & Current Investments (Quarterly) stood at $94.9 million in 2023, then skyrocketed by 49.73% to $152.5 million in 2024.
- Its Cash & Current Investments stands at $152.5 million for Q3 2024, versus $166.4 million for Q2 2024 and $193.7 million for Q1 2024.